US Map / Mississippi
State MS

Clinical Trials in Mississippi

Recruiting clinical trials with at least one study location in Mississippi. Data updated daily from ClinicalTrials.gov.

Total Trials
58
Recruiting Now
58
← Back to US Map
Top Conditions in Mississippi
Chronic Lymphocytic Leukemia (2)Small Lymphocytic Lymphoma (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Hypertension (2)Non-small Cell Lung Cancer (1)Opioid Use Disorder (1)Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Head and Neck Squamous Cell Carcinoma (1)Hypopharyngeal Squamous Cell Carcinoma (1)Laryngeal Squamous Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Mississippi

How many clinical trials are currently recruiting in Mississippi?
ClinicalMetric currently tracks 58 actively recruiting clinical trials with at least one location in Mississippi. The total number of registered studies—including active but not currently enrolling trials—is 58. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Mississippi?
Mississippi hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Mississippi serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Mississippi?
To join a clinical trial in Mississippi, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Mississippi maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Mississippi

NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
View Trial →
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT06872307 N/A
Recruiting
Intervention to Enhance PrEP Persistence
Condition
HIV Prevention
Enrollment
300 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT05787821 N/A
Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Condition
Knee Pain Chronic
Enrollment
760 pts
Location
United States
Sponsor
Zimmer Biomet
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05692180 Phase 3
Recruiting
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim...
Condition
Asthma
Enrollment
200 pts
Location
United States, Argentina, Canada
Sponsor
AstraZeneca
View Trial →
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
View Trial →
NCT06976203 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Imp...
Condition
Alzheimer's Disease
Enrollment
586 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT04064359 Phase 1
Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid T...
Condition
Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, France
Sponsor
Oxford BioTherapeutics Ltd
View Trial →
NCT07284472 Phase 2, Phase 3
Recruiting
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzh...
Condition
Agitation Associated With Alzheimer's Disease Dementia
Enrollment
300 pts
Location
United States, Canada, United Kingdom
Sponsor
Exciva GmbH
View Trial →
NCT05687058 Phase 1, Phase 2
Recruiting
Empagliflozin in ESKD - A Feasibility Study
Condition
Kidney Failure, Chronic
Enrollment
24 pts
Location
United States
Sponsor
University of Mississippi Medi
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05797610 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Partici...
Condition
Primary IgA Nephropathy
Enrollment
428 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT02989025 Phase 2
Recruiting
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm ...
Condition
Pregnancy
Enrollment
60 pts
Location
United States
Sponsor
University of Mississippi Medi
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06758401 Phase 3
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvot...
Condition
Non-Small Cell Lung Cancer
Enrollment
714 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT06951711 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic ...
Condition
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Enrollment
274 pts
Location
United States, Croatia, India
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05339139 Phase 3
Recruiting
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Condition
Acute Kidney Injury
Enrollment
50 pts
Location
United States
Sponsor
Fresenius Medical Care North A
View Trial →
NCT06938347 Phase 3
Recruiting
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Rig...
Condition
Right-To-Left Shunt
Enrollment
300 pts
Location
United States, Canada
Sponsor
Agitated Solutions, Inc.
View Trial →
NCT06588478 Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With...
Condition
Chronic Lymphocytic Leukemia
Enrollment
249 pts
Location
United States, Australia, Belgium
Sponsor
Loxo Oncology, Inc.
View Trial →
Page 1 of 3 — 58 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology